Home 2019-10-22T00:10:32-05:00

The Most Advanced Cancer Immunotherapy Treatments.

When you have cancer, you don’t have time to wait for today’s scientific advances to become standard treatment years from now, you need those today. We bring you the treatments of the future, today.

  • Breast Cancer
  • Lung Cancer
  • Cervical Cancer
  • Colon Cancer
  • Prostate Cancer
  • Liver Cancer
  • Head and Neck Cancer
  • Pancreatic Cancer
  • Ovarian Cancer
  • Uterine Cancer
  • Lymphoma
  • Sarcoma
  • Melanoma

The Immunotherapy Revolution

The Future Of Treating Cancer Has Finally Arrived.

Cancer treatments can be torture! Surgery, chemotherapy, and radiation are not only extreme but can be just as painful and dangerous as the cancer itself.

When doctors treat cancer aggressively it leaves the body in a weakened, susceptible state open to contracting other diseases or relapses. Most of the medical field refuses to acknowledge the major problems with the way they treat cancer.

So is there really a better way to heal from cancer against all odds? YES!

Grab your copy now, and discover the promising solution to cancer!

This book is a must read for all cancer patients.

Click Here to Get Your Copy

Leaders For A Cure Awardee

Congratulations to Dr. Jason Williams, MD on being the recipient of the Vince Lombardi Cancer Foundation’s “Leaders For A Cure Award.” His work in the cancer field is world renowned.

Click Here for More Details

Are You a Candidate?

To determine if you are a candidate for one of our cancer treatment procedures, please contact 251-943-9409. We will need to see copies of the most recent medical records and imaging studies. We provide a review of these records at no cost; however, please do not send original documents as they will not be returned.

Click Here to Learn More

Your Advanced Cancer Treatment Procedures

New, precision approaches to cancer treatment that target and attack the tumor directly.

Intratumoral Immunotherapy

Intratumoral Immunotherapy

Immunotherapy agents such as the immune checkpoint inhibitors Opdivo, Keytruda, Yervoy and OX40 agonist have been a revolution in cancer treatment, but they still have tremendous limitations. Studies have shown injecting these agents directly into a tumor may allow for more combinations, better success and less side effects than the typical intravenous administration. It is important to understand that this treatment is systemic, meaning it affects other tumors that are not directly injected. This means it is not needed to inject every tumor in cases where patients may have many. Also, patients already receiving intravenous immunotherapy may benefit by adding intratumoral immunotherapy to enhance their treatment. In addition, new experimental agents, such as an OX40 agonist, combined with CpG (called the Stanford cancer vaccine) have created even more excitement. This combination injected into the tumor, made worldwide news in early 2018, showing outstanding success with the idea of treating directly at a tumor site. The studies indicate that treating one or two sites can result in a whole body anti-cancer immune response. The idea is that training the immune system at the site where it actually encounters the cancer is the most important, not just all throughout the body. These trained immune cells can then attack cancer in locations throughout the body.

Cryoablation combined with Injection of Immunotherapy

Studies have shown that using image guided Cryoablation, a technique where a needle is placed into a tumor, then frozen, can enhance an anti-cancer immune response even in distant tumors. Further studies indicate that using this technique, combined with the injection of immunotherapy agents into the ablation and tumor site, can significantly enhance the effectiveness of the immune response, far more than just the medications or Cryoablation alone.

Cryoablation combined with Injection of Immunotherapy
Intravenous Immunotherapy

Intravenous Immunotherapy combined with Intratumoral Injection of Immunotherapy

We offer unique combinations of immunotherapy that are enhanced with intratumoral injection and off label immune augmenting medications. In addition, if you are already receiving immunotherapy, or even chemotherapy, we can work with you and your doctor by adding image-guided injection of immunotherapy to boost your current treatment.

Breast Cancer Cryoablation

The future of breast cancer treatment, a minimally invasive procedure that can be essentially “scarless.” In addition, techniques such as vaccine adjuvants can be used to enhance the anti-cancer immune response of the Cryoablation procedure. We use techniques to minimize the spread and recurrence of cancer, such as the injection of NSAIDS (Ketorolac) directly into the tumor site when we perform ablations or biopsies.

Breast Cancer Cryoablation

What is Cryoablation?

Cryoablation is the placement of a needle into the tumor, freezing the tissue to destroy it. Typically this is for limited disease, but when combined with immunotherapy it can be helpful even in advanced cancers. This is because Cryoablation releases dead pieces of tumor that can be detected by the immune system, combined with immunotherapy; this functions like a cancer vaccine. See the video below for an explanation.

Lung Cancer Ablation

Delivers larger amounts of medication to the tumor with a lower dosage to you.

Breast Cryoablation

A less-invasive advantage for treating breast cancer.

Meet the Physicians


Director of Interventional Oncology and Immunotherapy, Image Guided Cancer Specialist, Williams Cancer Institute

Jason R. Williams is a medical doctor, board-certified radiologist, image-guided cancer specialist, researcher, and professor. He is one of the pioneers of immunotherapy, specializing in intra-tumoral interventions. He performed the world’s first ablation procedure and implemented an intra-tumoral injection of a specific combination of immunotherapy agents, thus leveraging the actual process of ablation as an immunotherapy agent itself. Since then, he has performed thousands of procedures —many of them “first in human”— in multiple areas of ablation and cryoablation therapies.

Read More >